KYPHA INC has a total of 20 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets measurement and pharmaceuticals are ORIBASE PHARMA, LUDWIG HANNS and CHINESE ACADEMY OF SCIENCES SH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Australia | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Canada | 2 | |
#6 | Mexico | 2 | |
#7 | Brazil | 1 | |
#8 | Hong Kong | 1 | |
#9 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Olson Paul | 17 |
#2 | Staten Nick | 8 |
#3 | Moss Donald | 6 |
#4 | Moss Donald W | 5 |
#5 | Paul Olson | 3 |
#6 | Moss Don W | 3 |
#7 | Donald W Moss | 3 |
#8 | Staten Nicholas | 2 |
#9 | Nick Staten | 2 |
#10 | Kim Alfred | 2 |
Publication | Filing date | Title |
---|---|---|
US2018275139A1 | Methods for predicting flare and improving treatment of patients | |
US2015056639A1 | Detecting complement activation | |
AU2013256496A1 | Detecting complement activation | |
WO2012071145A1 | Lateral flow immunoassay for complement activation and methods of use for point-of-care assessment of complement-associated disorders |